Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Nancy Wakeham"'
Autor:
Richard A. Bunce, William W. Barrow, Christina R. Bourne, Esther W. Barrow, K. Darrell Berlin, Baskar Nammalwar, Nancy Wakeham, Philip C. Bourne, N. Prasad Muddala
Publikováno v:
Bioorganic & Medicinal Chemistry. 23:203-211
The current Letter describes the synthesis and biological evaluation of dihydrophthalazine-appended 2,4-diaminopyrimidine (DAP) inhibitors (1) oxidized at the methylene bridge linking the DAP ring to the central aromatic ring and (2) modified at the
Autor:
Nicole Webb, William W. Barrow, Nancy Wakeham, Christina R. Bourne, K. Darrell Berlin, Baskar Nammalwar, Richard A. Bunce
Publikováno v:
Biochemistry
We are addressing bacterial resistance to antibiotics by repurposing a well-established classic antimicrobial target, the dihydrofolate reductase (DHFR) enzyme. In this work, we have focused on Enterococcus faecalis, a nosocomial pathogen that freque
Autor:
K. Darrell Berlin, Richard A. Bunce, Baskar Nammalwar, William W. Barrow, Shankari Mylvaganam, Philip C. Bourne, Christina R. Bourne, Esther W. Barrow, Nancy Wakeham, Kal Ramnarayan
Publikováno v:
ChemMedChem. 7:1974-1982
A series of (±)-6-alkyl-2,4-diaminopyrimidine-based inhibitors of bacterial dihydrofolate reductase (DHFR) have been prepared and evaluated for biological potency against Bacillus anthracis and Staphylococcus aureus. Biological studies reveal attenu
Autor:
Nancy Wakeham, Christina R. Bourne, Baskar Nammalwar, Richard A. Bunce, William W. Barrow, K. Darrell Berlin
Publikováno v:
Journal of Molecular Recognition. 25:216-223
Drug development programs have proven successful when performed at a whole cell level, thus incorporating solubility and permeability into the primary screen. However, linking those results to the target within the cell has been a major setback. The
Autor:
Guangyu Zhu, Guangpu Li, Joseph S. Brunzelle, Bo Huang, Simon Terzyan, Jay Liu, Zihe Rao, Jia Chen, Xuemei Li, Nancy Wakeham, Xuejun C. Zhang
Publikováno v:
The EMBO Journal
APPL1 is an effector of the small GTPase Rab5. Together, they mediate a signal transduction pathway initiated by ligand binding to cell surface receptors. Interaction with Rab5 is confined to the amino (N)-terminal region of APPL1. We report the crys
Autor:
Guangyu Zhu, Nancy Wakeham, Xuejun C. Zhang, Karla K. Rodgers, Peng Zhai, Guangpu Li, Xiangyuan He, Jordan Tang
Publikováno v:
The EMBO Journal. 23:3909-3917
GGA proteins coordinate the intracellular trafficking of clathrin-coated vesicles through their interaction with several other proteins. The GAT domain of GGA proteins interacts with ARF, ubiquitin, and Rabaptin5. The GGA-Rabaptin5 interaction is bel
Publikováno v:
Proteins: Structure, Function, and Bioinformatics. 56:277-284
Streptokinase (SK) is a human plasminogen (Pg) activator secreted by streptococci. The activation mechanism of SK differs from that of physiological Pg activators in that SK is not a protease and cannot proteolytically activate Pg. Instead, it forms
Autor:
Xuejun C. Zhang, Guangyu Zhu, Jian Liu, Guangpu Li, Nancy Wakeham, Xiangyuan He, Jordan Tang, Peng Zhai
Publikováno v:
Biochemistry. 42:13901-13908
GGA proteins regulate clathrin-coated vesicle trafficking by interacting with multiple proteins during vesicle assembly. As part of this process, the GAT domain of GGA is known to interact with both ARF and Rabaptin-5. Particularly, the GAT domains o
Autor:
Nancy Wakeham, Celeste R. Wirsig-Wiechmann, Marie H. Hanigan, Elizabeth M. Gillies, Stephanie Wickham
Publikováno v:
Histochemistry and cell biology. 143(5)
Gamma-glutamyl transferase (GGT5) was discovered due to its ability to convert leukotriene C4 (LTC4, a glutathione S-conjugate) to LTD4 and may have an important role in the immune system. However, it was not known which cells express the enzyme in h
Autor:
Christina R. Bourne, Esther W. Barrow, Vladimir Tseitin, Kal Ramnarayan, K. Darrell Berlin, William W. Barrow, Philip C. Bourne, Richard A. Bunce, Nancy Wakeham, Baskar Nammalwar, Shankari Mylvaganam
Background: Bacterial resistance to antibiotic therapies is increasing and new treatment options are badly needed. There is an overlap between these resistant bacteria and organisms classified as likely bioterror weapons. For example, Bacillus anthra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b4365355cfa9cfeee643025baf14bbf
https://europepmc.org/articles/PMC3530638/
https://europepmc.org/articles/PMC3530638/